Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

1 Jan 2017

Abstract excerpt

Emerging Microbes & Infections (2017) 6, e60; doi:10.1038/emi.2017.50; published online 28 June 2017

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28655936
DOI: 10.1038/emi.2017.50

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinPMID 28655936Read ↗

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinSemantic proximity Read ↗

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.Semantic proximity Read ↗

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoproteinSemantic proximity Read ↗

Synthetic Monoclonal Antibody Designed for Novel SARS-nCoV-2 Spike-S1 Protein Antigenic Targeted Epitope of Receptor Binding Domain Inhibit to Prevent Viral EntrySemantic proximity Read ↗

Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variantsSemantic proximity Read ↗

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.Semantic proximity Read ↗

Broadly neutralizing antibodies against COVID-19Semantic proximity Read ↗

Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody TargetingSemantic proximity Read ↗

Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike proteinSemantic proximity Read ↗

Neutralizing antibodies targeting SARS-CoV-2 spike proteinSemantic proximity Read ↗

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunitySemantic proximity Read ↗

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.